Impact of azithromycin on specific biochemical markers and sebum composition in acne vulgaris patients.

IF 2.1 4区 医学 Q3 DERMATOLOGY
Alaa Sh Abdulbari, Noor M Ali, Ahmed Rahmah Abu-Raghif, Nadheer A Matloob, Hayder Ridha-Salman
{"title":"Impact of azithromycin on specific biochemical markers and sebum composition in acne vulgaris patients.","authors":"Alaa Sh Abdulbari, Noor M Ali, Ahmed Rahmah Abu-Raghif, Nadheer A Matloob, Hayder Ridha-Salman","doi":"10.1007/s00403-025-04299-4","DOIUrl":null,"url":null,"abstract":"<p><p>Acne vulgaris (AV) is a persistent inflammatory skin disease that affects the pilosebaceous units. Oral azithromycin has shown significant effectiveness in treating AV, attributed to its robust anti-inflammatory and antimicrobial properties. This study aimed to evaluate the efficacy of azithromycin in patients with moderate-to-severe AV, with a focus on its influence on sebum composition and specific biomarkers, including pyridoxine (B6), biotin (B7), cobalamin (B12) (measured by HPLC), and homocysteine (measured by ELISA). A case-control study was conducted at the dermatology department of Al-Imamain-Alkadhimain Medical City, Baghdad. The study included thirty patients aged 15-35 years with moderate-to-severe AV, and thirty healthy individuals of the same age and sex served as a control group. Patients received 500 mg of azithromycin on alternate days for 12 weeks. Laboratory and clinical parameters were assessed at baseline and compared to the control group, then re-evaluated after treatment. The findings indicated a significant decrease in serum levels of folic acid, B7, and B6 at both 6 and 12 weeks post-treatment (p < 0.05). Serum homocysteine levels increased slightly over time, but this change was not statistically significant (p > 0.05). No significant difference in serum B12 levels was observed at 6 weeks (p > 0.05); however, a significant increase was noted at 12 weeks (p < 0.05). Clinical score, skin moisture, and sebum squalene (Sebum-SQ) content improved significantly post-treatment (p < 0.05), while sebum cholesterol (Sebum-Chol.) levels showed significant change only at 12 weeks (p < 0.05). The finding supports the efficacy of azithromycin in managing inflammatory acne and modulating sebum composition and specific biomarkers. However, the relatively small sample size and absence of power analysis limit the generalizability of the results. Future studies with larger cohorts are recommended to validate these findings.</p>","PeriodicalId":8203,"journal":{"name":"Archives of Dermatological Research","volume":"317 1","pages":"798"},"PeriodicalIF":2.1000,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Dermatological Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00403-025-04299-4","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Acne vulgaris (AV) is a persistent inflammatory skin disease that affects the pilosebaceous units. Oral azithromycin has shown significant effectiveness in treating AV, attributed to its robust anti-inflammatory and antimicrobial properties. This study aimed to evaluate the efficacy of azithromycin in patients with moderate-to-severe AV, with a focus on its influence on sebum composition and specific biomarkers, including pyridoxine (B6), biotin (B7), cobalamin (B12) (measured by HPLC), and homocysteine (measured by ELISA). A case-control study was conducted at the dermatology department of Al-Imamain-Alkadhimain Medical City, Baghdad. The study included thirty patients aged 15-35 years with moderate-to-severe AV, and thirty healthy individuals of the same age and sex served as a control group. Patients received 500 mg of azithromycin on alternate days for 12 weeks. Laboratory and clinical parameters were assessed at baseline and compared to the control group, then re-evaluated after treatment. The findings indicated a significant decrease in serum levels of folic acid, B7, and B6 at both 6 and 12 weeks post-treatment (p < 0.05). Serum homocysteine levels increased slightly over time, but this change was not statistically significant (p > 0.05). No significant difference in serum B12 levels was observed at 6 weeks (p > 0.05); however, a significant increase was noted at 12 weeks (p < 0.05). Clinical score, skin moisture, and sebum squalene (Sebum-SQ) content improved significantly post-treatment (p < 0.05), while sebum cholesterol (Sebum-Chol.) levels showed significant change only at 12 weeks (p < 0.05). The finding supports the efficacy of azithromycin in managing inflammatory acne and modulating sebum composition and specific biomarkers. However, the relatively small sample size and absence of power analysis limit the generalizability of the results. Future studies with larger cohorts are recommended to validate these findings.

阿奇霉素对寻常痤疮患者特异性生化指标及皮脂组成的影响。
寻常痤疮(AV)是一种持续的炎症性皮肤病,影响毛囊皮脂腺单位。口服阿奇霉素由于其强大的抗炎和抗菌特性,在治疗AV方面显示出显著的有效性。本研究旨在评估阿奇霉素对中重度AV患者的疗效,重点关注其对皮脂组成和特定生物标志物的影响,包括吡哆醇(B6)、生物素(B7)、钴胺素(B12) (HPLC测定)和同型半胱氨酸(ELISA测定)。在巴格达Al-Imamain-Alkadhimain医疗城皮肤科进行了一项病例对照研究。该研究包括30名年龄在15-35岁的中重度AV患者,以及30名相同年龄和性别的健康个体作为对照组。患者每隔一天给予500毫克阿奇霉素,持续12周。在基线时评估实验室和临床参数,并与对照组进行比较,然后在治疗后重新评估。结果显示,治疗后6周和12周血清叶酸、B7和B6水平显著降低(p 0.05)。6周时血清B12水平差异无统计学意义(p < 0.05);然而,在12周时显著增加(p
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.10
自引率
3.30%
发文量
30
审稿时长
4-8 weeks
期刊介绍: Archives of Dermatological Research is a highly rated international journal that publishes original contributions in the field of experimental dermatology, including papers on biochemistry, morphology and immunology of the skin. The journal is among the few not related to dermatological associations or belonging to respective societies which guarantees complete independence. This English-language journal also offers a platform for review articles in areas of interest for dermatologists and for publication of innovative clinical trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信